Andorra vs Saint Kitts and Nevis: Tuberculosis treatment success rate by type
Andorra
100
in 2022
Saint Kitts and Nevis
100
in 2019
Andorra rank
1st
Saint Kitts and Nevis rank
1st
Tuberculosis treatment success rate by type over time
- Andorra
- Saint Kitts and Nevis
How they compare
Andorra currently reports 100 against 100 in Saint Kitts and Nevis, a difference of 0.
The two have swapped places 5 times across 13 shared years of data; in 1998 it was Andorra ahead.
Andorra ranks 1st and Saint Kitts and Nevis ranks 1st of 194 countries.
Andorra has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 83.5 | 37.5 | 46 | Andorra |
| 2000s | 91.33 | 47.5 | 43.83 | Andorra |
| 2010s | 89.2 | 80 | 9.2 | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Andorra or Saint Kitts and Nevis?
- Andorra, at 100 against 100 in Saint Kitts and Nevis as of 2022.
- What is the difference in tuberculosis treatment success rate by type between Andorra and Saint Kitts and Nevis?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Saint Kitts and Nevis?
- 13 years are reported by both, from 1998 to 2019.
- How do Andorra and Saint Kitts and Nevis rank globally for tuberculosis treatment success rate by type?
- Andorra ranks 1st and Saint Kitts and Nevis ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.